Business Context and Reporting Period
This Form 8-K filing by CHF Solutions, Inc. (Note: The metadata references Nuwellis, Inc., but the filing text identifies the registrant as CHF Solutions, Inc.) covers events occurring between January 24, 2020, and January 28, 2020. The report details the entry into a material definitive agreement for a registered public offering and the subsequent closing of that offering.
Key Financial Metrics and Capital Structure
- Net Proceeds: Approximately $8.6 million after deducting underwriting discounts, commissions, and estimated offering expenses.
- Offering Price: $0.55 per Unit (Class A and Class B).
- Securities Issued:
- 6,046,367 shares of Common Stock (including 2,290,909 from the full exercise of the overallotment option).
- 11,517,269 shares of Series H Convertible Preferred Stock.
- Warrants to purchase 17,563,636 shares of Common Stock (exercise price $0.55, 5-year term).
- Post-Offering Capitalization (as of Jan 28, 2020):
- 15,251,797 shares of Common Stock outstanding.
- 535 shares of Series F Preferred Stock (convertible into 973,165 Common Stock shares).
- 6,985,907 shares of Series H Preferred Stock (convertible into 6,985,907 Common Stock shares).
Note: The filing does not provide specific revenue, profit, cash flow, or debt figures for the reporting period.
Material Changes
- Equity Dilution and Conversion Price Adjustment: The Public Offering price of $0.55 triggered a full-ratchet anti-dilution provision for the outstanding Series F Convertible Preferred Stock. Consequently, the conversion price for Series F Preferred Stock was reduced to $0.55, effective upon the closing of the offering.
- Capital Structure Expansion: The company significantly increased its authorized and outstanding equity through the issuance of new Common Stock, Series H Preferred Stock, and Warrants.
- Lock-Up Period: The Company and its executive officers and directors agreed to a 90-day lock-up period, restricting the sale or transfer of Company securities without the Underwriter's prior written approval.
Outlook, Risks, and Unusual Items
- Warrant Terms: Warrants are subject to beneficial ownership limitations (4.99% or 9.99% at election) and anti-dilution adjustments if future equity sales occur at a price lower than the $0.55 exercise price (subject to a 10% floor).
- Series H Preferred Stock Rights: Holders of Series H Preferred Stock have limited voting rights but possess veto power over changes to their rights, amendments to charter documents affecting them, or increases in authorized Series H shares. The Company retains the right to force conversion if the Common Stock price exceeds 300% of the conversion price for 20 of 30 consecutive trading days with sufficient volume.
- Indemnification: The Company agreed to indemnify the Underwriter against certain liabilities under the Securities Act of 1933.
Investor Verification Checklist
- Verify the exact net proceeds received ($8.6 million estimate) against the final closing statement.
- Confirm the impact of the Series F conversion price reduction on existing shareholder dilution.
- Review the full text of the Underwriting Agreement (Exhibit 1.1) for specific covenants and indemnification limits.
- Monitor the 90-day lock-up expiration date for potential selling pressure from insiders.
- Assess the liquidity impact of the 17.5 million warrants outstanding exercisable at $0.55.